Webinar banner for Bridging Data Sources to Facilitate Accurate Incidence and Prevalence Estimates in DAP Goal Setting

マルチソースデータの統合が、ターゲット集団の特定、臨床試験デザインの改善、そして多様性行動計画の作成にどのように役立つかをご覧ください。

ビッグデータは、マイノリティ集団やその他の代表的でない集団が歴史的に十分にカウントされていないギャップを特定するのに役立つ......。
フェンウィック・エックハート、シテライン、臨床新製品開発担当シニアマネージャー

注目のスピーカー

Headshot of Fenwick Eckhardt

Fenwick Eckhardt

Head of Diversity Strategy, Citeline

Fenwick Eckhardt is head of diversity strategy at Citeline. She is dedicated to revolutionizing the life sciences industry through cutting-edge solutions that harness real-world data, technology, and analytics. With over five years of experience in pharma and biotech, Fenwick excels in optimizing clinical trial design and outcomes to expedite the delivery of life-saving therapies. She holds a master’s degree from Imperial College London and a bachelor’s in human physiology from Boston University.

Related resources

Patients in a waiting room with healthcare professionals.
JUN 27, 2024
Article
Clinical

Deciphering the FDA Diversity Plan Updated Guidance

On June 26, the FDA released updated guidance on diversity action plans. See what the guidance means for clinical trial sponsors.

''
AUG 14, 2024
Infographic
Clinical

Unlock Diversity in Clinical Trials: Top 10 Tips for Crafting a Successful Action Plan

The FDA has updated its guidance on diversity action plans for clinical trials. See the top 10 tips on how to craft a successful action plan.

''
JUL 19, 2024
Article
薬事規制関連支援サービス

Clinical Trial Diversity Action Plans Will Take 100 Hours to Prepare

Drug and biologic product sponsors will spend on average 100 hours to prepare and submit each clinical trial diversity action plan required under a 2022 law, the FDA estimates.